New Age Alpha Advisors LLC Sells 12,776 Shares of Medtronic PLC $MDT

New Age Alpha Advisors LLC lowered its position in shares of Medtronic PLC (NYSE:MDT) by 54.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,551 shares of the medical technology company’s stock after selling 12,776 shares during the quarter. New Age Alpha Advisors LLC’s holdings in Medtronic were worth $1,014,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in MDT. Lodestone Wealth Management LLC acquired a new stake in Medtronic in the fourth quarter worth about $27,000. Anfield Capital Management LLC increased its position in Medtronic by 410.7% in the fourth quarter. Anfield Capital Management LLC now owns 286 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 230 shares during the period. Board of the Pension Protection Fund acquired a new stake in Medtronic in the fourth quarter worth about $29,000. GoalVest Advisory LLC acquired a new stake in Medtronic in the fourth quarter worth about $29,000. Finally, Valley Wealth Managers Inc. acquired a new stake in Medtronic in the third quarter worth about $29,000. Institutional investors own 82.06% of the company’s stock.

Medtronic News Summary

Here are the key news stories impacting Medtronic this week:

• Positive Sentiment: Medtronic announced its intention to acquire SPR Therapeutics, a move that could expand its pain-management portfolio and support longer-term growth. Medtronic plc (MDT) Announces Intention to Acquire SPR Therapeutics (SPR)
• Positive Sentiment: Analysts noted broad MedSurg, cardiovascular, and diabetes strength could help Medtronic’s fiscal Q4 results, suggesting some underlying operational support. Broad-Based MedSurg Growth Likely to Aid MDT’s Q4 Performance
• Neutral Sentiment: Medtronic is expected to report earnings on Wednesday, keeping investors focused on whether results and guidance can reset expectations. Medtronic (MDT) Expected to Announce Earnings on Wednesday
• Neutral Sentiment: Industry comparisons continue to highlight competition in surgical robotics, with Intuitive Surgical seen as having the stronger growth profile than Medtronic’s Hugo platform. ISRG vs. MDT: Which Surgical Robot Stock Is the Better Buy?
• Negative Sentiment: Analysts are looking for a decline in Medtronic’s earnings and say the company may not have the right setup for an earnings beat, which is weighing on sentiment ahead of the report. Analysts Estimate Medtronic (MDT) to Report a Decline in Earnings: What to Look Out for
• Negative Sentiment: Recent trading showed the stock weakening despite a broader market gain, reinforcing cautious investor sentiment. Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note

Wall Street Analysts Forecast Growth

A number of analysts recently commented on MDT shares. Argus lowered their price objective on Medtronic from $125.00 to $115.00 and set a “buy” rating for the company in a research report on Monday, April 6th. Wells Fargo & Company started coverage on Medtronic in a research report on Friday, January 30th. They issued an “overweight” rating and a $114.00 price objective for the company. Weiss Ratings lowered Medtronic from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Leerink Partners reiterated an “outperform” rating and issued a $119.00 price objective on shares of Medtronic in a research report on Tuesday, March 10th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $120.00 price objective on shares of Medtronic in a research report on Thursday, March 26th. Fifteen analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $106.45.

Medtronic Trading Down 2.1%

NYSE MDT opened at $75.98 on Thursday. The stock has a 50-day simple moving average of $82.89 and a 200 day simple moving average of $92.90. The company has a market capitalization of $97.55 billion, a PE ratio of 21.16, a P/E/G ratio of 1.85 and a beta of 0.62. The company has a current ratio of 2.54, a quick ratio of 1.87 and a debt-to-equity ratio of 0.57. Medtronic PLC has a 12 month low of $74.40 and a 12 month high of $106.33.

Medtronic Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 17th. Investors of record on Friday, March 27th were issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 3.7%. The ex-dividend date was Friday, March 27th. Medtronic’s dividend payout ratio is currently 79.11%.

Medtronic Company Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).